All News

Officials with the FDA have approved Alkermes' aripiprazole lauroxil (Aristada Initio) extended-release product for the treatment of schizophrenia in adults.

Officials with the FDA have approved an Alkermes aripiprazole lauroxil (Aristada Initio) extended-release product for the treatment of schizophrenia in adults, according to the company.

An investigational anti-cancer vaccine will be paired with nivolumab to determine whether the combination therapy will improve survival in patients with the disease.

Basket studies can be useful to determine if a drug targeting a certain genetic mutation at a particular site may be effective in treating that same genetic mutation found in cancer located in another site of the body.

Being prepared is vital to understanding and resolving future drug shortages.

Tobacco is the leading cause of premature mortality among adults living with HIV.

Three pain societies have come together to create consensus guidelines for treating both acute and chronic pain with ketamine, an old drug seeing a resurgence.

The device, Pulmonx’s Zephyr Endobronchial Valve (Zephyr Valve) is a less invasive treatment than options currently available to patients.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Two recent clinical trials evaluated the efficacy of the drug ozanimod, an investigational drug for the treatment of relapsing multiple sclerosis.

EPS has released a new 10-pack configuration for all 4 sizes of its Steri-Dropper® sterile ophthalmic dispensing containers.

A new device intended to treat breathing difficulty associated with severe emphysema has been approved by the FDA.

Top news of the week from Specialty Pharmacy Times.

Ophthalmic compounding and dispensing can be an expensive and highly technical task.

Glasdegib, in addition to chemotherapy, offers an additional treatment option for patients with acute myeloid leukemia who are ineligible for intensive chemotherapy.

Top news of the day from across the health care landscape

Top news of the day from across the health care landscape.

A study of 39 men found that those affected by migraine had higher levels of estradiol, an estrogen, than those without migraine.

Top news of the week from The American Journal of Pharmacy Benefits.

The study emphasizes the need for harm reduction interventions that include access to syringes and sterile injection equipment, in addition to comprehensive HIV prevention services.

Amazon will start prescription delivery with a focus on customer service and convenience.

How changes related to Brexit may influence regulatory, research, and economic perspectives, as well as human health.

The massive online retailer is entering the online pharmacy world with its acquisition of PillPack.

Researchers at the University of Virginia developed an app called PositiveLinks to test out whether interactive smartphone functions and reminders could have a real-world impact on the health of HIV-positive patients.

Patients with melanoma who were treated with a combination of radiosurgery and anti-PD-1 immunotherapy experienced better outcomes compared with patients who received anti-CTLA4 immunotherapy.

The FDA has granted approval to Array BioPharma’s encorafenib (Braftovi) capsules in combination with binimetinib (Mektovi) tablets for the treatment of patients with unresectable or metastatic melanoma with BRAFV600E or BRAFV600K mutation.

The United States Preventive Services Task Force (USPSTF) updated its 2011 recommendation about osteoporosis screening.

Top news of the day from across the health care landscape

Top news of the day from across the health care landscape